APA (7th ed.) Citation

Banys-Paluchowski, M., Fehm, T., Janni, W., Aktas, B., Fasching, P. A., Kasimir-Bauer, S., . . . Müller, V. (2018). Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).

Chicago Style (17th ed.) Citation

Banys-Paluchowski, Malgorzata, et al. Elevated Serum RAS P21 Is an Independent Prognostic Factor in Metastatic Breast Cancer. Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2018.

MLA (9th ed.) Citation

Banys-Paluchowski, Malgorzata, et al. Elevated Serum RAS P21 Is an Independent Prognostic Factor in Metastatic Breast Cancer. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2018.